HA

HAMELN PHARMA APS

Org.nr: 927 826 291

Aktiv UTLA I Foretaksregisteret

Hameln Pharma is an internationally operating, owner‑managed pharmaceutical group that develops, licenses, and markets high‑quality generic injectable medicines for hospitals, pharmacies, outpatient surgery centres, and palliative care. Their portfolio includes analgesics, anesthetics, sedatives, antiemetics, antidotes, and opioids, serving customers in over 45 countries.